Hydroxyprogesterone Caproate
Back to searchMolecule Structure
Scientific Name
Hydroxyprogesterone Caproate
Description of the Drug
Hydroxyprogesterone caproate is a synthetic progestin used for the prevention of spontaneous preterm births in singleton pregnancies in women who have previously had a spontaneous preterm birth.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06789
http://www.drugbank.ca/drugs/DB06789
Brand Name(s)
Delalutin, Hydroxyprogesterone caproate, Makena, Makena (autoinjector), Makena preservative free, Proluton depot
Company Owner(s)
Aspen Pharma Usa Inc, Bristol Myers Squibb, Covis Pharma Gmbh, Sun Pharmaceutical Industries Ltd, Aspen Global Inc, American Regent Inc, Amag Pharma Usa Inc, Eugia Pharma Specialities Ltd, Allergan Sales Llc, Slayback Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Progesterone receptor | SINGLE PROTEIN | AGONIST | CHEMBL208 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5330 |
| DrugBank | DB06789 |
| PubChem: Thomson Pharma | 15007174 |
| PubChem | 169870 |
| Nikkaji | J6.891H |
| BindingDB | 70293 |
| EPA CompTox Dashboard | DTXSID6043915 |
| DrugCentral | 4189 |
| ChemicalBook | CB1702877 |
| rxnorm | MAKENA |
| KEGG Ligand | C08148 |
| ChEBI | 5812 |
| ZINC | ZINC000004083606 |
